Variant report
Variant | esv3520381 |
---|---|
Chromosome Location | chr1:185009798-185011741 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:5)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:5 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr1:185010103-185010393 | K562 | blood: | n/a | chr1:185010245-185010256 |
2 | CEBPB | chr1:185010099-185010331 | HepG2 | liver: | n/a | chr1:185010245-185010256 |
3 | GATA3 | chr1:185010658-185010823 | SH-SY5Y | brain: | n/a | chr1:185010748-185010757 |
4 | POLR2A | chr1:185009472-185009897 | SK-N-MC | brain: | n/a | n/a |
5 | ZNF384 | chr1:185010197-185010384 | K562 | blood: | n/a | n/a |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:185010943..185013509-chr1:185124566..185127368,2 | MCF-7 | breast: | |
2 | chr1:184983211..184985118-chr1:185007746..185010406,2 | K562 | blood: | |
3 | chr1:185010303..185011857-chr1:185026196..185028630,2 | K562 | blood: | |
4 | chr1:185000396..185004587-chr1:185007338..185010464,3 | K562 | blood: | |
5 | chr1:185010844..185012522-chr1:185016130..185018992,2 | MCF-7 | breast: | |
6 | chr1:185010099..185012707-chr1:185046027..185047994,2 | K562 | blood: | |
7 | chr1:185009803..185012714-chr1:185013040..185014804,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RNF2 | TF binding region |
ENSG00000116668 | chromatin interactions |
ENSG00000201312 | chromatin interactions |
ENSG00000121486 | chromatin interactions |
ENSG00000121481 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs555909976 | chr1:185009802-185009803 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs372630294 | chr1:185009806-185009807 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
3 | rs375322704 | chr1:185009807-185009808 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
4 | rs542646530 | chr1:185009851-185009852 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
5 | rs535041514 | chr1:185009955-185009956 | Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs74646539 | chr1:185009965-185009966 | Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs578183135 | chr1:185009987-185009988 | Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs560013325 | chr1:185009988-185009989 | Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs372915988 | chr1:185010010-185010011 | Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs575472079 | chr1:185010024-185010025 | Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs111679169 | chr1:185010060-185010061 | Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs531888901 | chr1:185010066-185010067 | Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs147713217 | chr1:185010111-185010112 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
14 | rs142839922 | chr1:185010147-185010148 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
15 | rs138777971 | chr1:185010177-185010178 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
16 | rs564758004 | chr1:185010181-185010182 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
17 | rs113589543 | chr1:185010219-185010220 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
18 | rs111870157 | chr1:185010250-185010251 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
19 | rs369994745 | chr1:185010256-185010257 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
20 | rs34739467 | chr1:185010294-185010295 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
21 | rs376089128 | chr1:185010305-185010306 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
22 | rs372464482 | chr1:185010312-185010313 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
23 | rs529920793 | chr1:185010324-185010325 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
24 | rs181446977 | chr1:185010333-185010334 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
25 | rs567765502 | chr1:185010347-185010348 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
26 | rs75667267 | chr1:185010368-185010369 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
27 | rs141599317 | chr1:185010378-185010379 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
28 | rs565493372 | chr1:185010386-185010387 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
29 | rs185935805 | chr1:185010420-185010421 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs527266709 | chr1:185010471-185010472 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs371099362 | chr1:185010477-185010478 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs75329977 | chr1:185010493-185010494 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs575386490 | chr1:185010629-185010630 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs190036916 | chr1:185010642-185010643 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs554332770 | chr1:185010679-185010680 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs572873889 | chr1:185010706-185010707 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs540002208 | chr1:185010714-185010715 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs564888846 | chr1:185010746-185010747 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs551501783 | chr1:185010757-185010758 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs374007417 | chr1:185010759-185010760 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs576918345 | chr1:185010804-185010805 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs566439664 | chr1:185010892-185010893 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs112304781 | chr1:185010969-185010970 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
44 | rs183111451 | chr1:185010999-185011000 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
45 | rs562795150 | chr1:185011192-185011193 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
46 | rs527320179 | chr1:185011226-185011227 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
47 | rs76943062 | chr1:185011239-185011240 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
48 | rs529882092 | chr1:185011294-185011295 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
49 | rs187843795 | chr1:185011307-185011308 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
50 | rs150904814 | chr1:185011327-185011328 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21509527 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Cancer | 17440070 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Nephroblastoma | 17189400 | CNVD |
Melanoma | 20688739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21611746 | CNVD |
Myelofibrosis | 22110671 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 17393978 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:185008600-185010200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr1:185009000-185010600 | Enhancers | Primary hematopoietic stem cells | blood |
3 | chr1:185009000-185010600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr1:185009400-185010200 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr1:185009400-185011000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
6 | chr1:185009600-185010200 | Enhancers | Fetal Muscle Leg | muscle |
7 | chr1:185010000-185010600 | Enhancers | Primary monocytes fromperipheralblood | blood |
8 | chr1:185010200-185010400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
9 | chr1:185010200-185014000 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
10 | chr1:185010200-185014000 | Weak transcription | Fetal Muscle Leg | muscle |
11 | chr1:185010400-185010600 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
12 | chr1:185010400-185010600 | Enhancers | Monocytes-CD14+_RO01746 | blood |
13 | chr1:185010600-185011000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
14 | chr1:185010600-185013600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
15 | chr1:185010600-185014000 | Weak transcription | Primary monocytes fromperipheralblood | blood |
16 | chr1:185010600-185014000 | Weak transcription | Primary hematopoietic stem cells | blood |
17 | chr1:185010600-185014000 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
18 | chr1:185011000-185014000 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
19 | chr1:185011000-185014000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |